These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35389242)

  • 1. Real-Life Feasibility of HIV Drug Resistance Testing Using Dried Filter Analytes in Kenyan Children and Adolescents Living with HIV.
    Manne A; DeLong A; Nyandiko W; DeLong AK; Vreeman R; Novitsky V; Ngeresa A; Sang E; Chory A; Aluoch J; Jepkemboi E; Orido M; Ashimosi C; Sang F; Hogan JW; Kantor R;
    Microbiol Spectr; 2022 Apr; 10(2):e0267521. PubMed ID: 35389242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.
    Kantor R; DeLong A; Balamane M; Schreier L; Lloyd RM; Injera W; Kamle L; Mambo F; Muyonga S; Katzenstein D; Hogan J; Buziba N; Diero L
    J Int AIDS Soc; 2014; 17(1):19262. PubMed ID: 25413893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
    Zhang G; DeVos J; Medina-Moreno S; Wagar N; Diallo K; Beard RS; Zheng DP; Mwachari C; Riwa C; Jullu B; Wangari NE; Kibona MS; Ng'Ang'A LW; Raizes E; Yang C
    PLoS One; 2018; 13(9):e0203296. PubMed ID: 30192818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings.
    Ziemniak C; Mengistu Y; Ruff A; Chen YH; Khaki L; Bedri A; Simen BB; Palumbo P; Eshleman SH; Persaud D
    J Clin Microbiol; 2011 Dec; 49(12):4077-82. PubMed ID: 21956987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
    Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
    J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya.
    Nyandiko W; Holland S; Vreeman R; DeLong AK; Manne A; Novitsky V; Sang F; Ashimosi C; Ngeresa A; Chory A; Aluoch J; Orido M; Jepkemboi E; Sam SS; Caliendo AM; Ayaya S; Hogan JW; Kantor R;
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):231-239. PubMed ID: 34723922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field study of dried blood spot specimens for HIV-1 drug resistance genotyping.
    Parry CM; Parkin N; Diallo K; Mwebaza S; Batamwita R; DeVos J; Bbosa N; Lyagoba F; Magambo B; Jordan MR; Downing R; Zhang G; Kaleebu P; Yang C; Bertagnolio S
    J Clin Microbiol; 2014 Aug; 52(8):2868-75. PubMed ID: 24871219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep/COBAS Taqman assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya.
    Zeh C; Ndiege K; Inzaule S; Achieng R; Williamson J; Chih-Wei Chang J; Ellenberger D; Nkengasong J
    PLoS One; 2017; 12(6):e0179316. PubMed ID: 28622370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
    Monleau M; Aghokeng AF; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Touré-Kane C; Truong LX; Chaix ML; Delaporte E; Ayouba A; Peeters M;
    J Clin Microbiol; 2014 Feb; 52(2):578-86. PubMed ID: 24478491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis.
    Rottinghaus E; Bile E; Modukanele M; Maruping M; Mine M; Nkengasong J; Yang C
    J Clin Microbiol; 2013 Jan; 51(1):55-60. PubMed ID: 23077127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a dried blood and plasma collection device, SampleTanker(®), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy.
    Diallo K; Lehotzky E; Zhang J; Zhou Z; de Rivera IL; Murillo WE; Nkengasong J; Sabatier J; Zhang G; Yang C
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):67-73. PubMed ID: 23944768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study.
    Pham MD; Haile BA; Azwa I; Kamarulzaman A; Raman N; Saeidi A; Kahar Bador M; Tan M; Zhu J; Feng Y; Elliott JH; Garcia ML; Li F; Crowe SM; Luchters S; Anderson DA
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30700508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting.
    Omooja J; Bbosa N; Lule DB; Nannyonjo M; Lunkuse S; Nassolo F; Nabirye SE; Suubi HN; Kaleebu P; Ssemwanga D
    BMC Infect Dis; 2022 May; 22(1):474. PubMed ID: 35581555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
    Mwau M; Schaffer S; Kimani H; Kasiano P; Ogolla F; Ajema E; Adoyo S; Nyairo E; Saleri N; Nair SV
    PLoS One; 2022; 17(8):e0269838. PubMed ID: 35994447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field Evaluation of Dried Blood Spots for HIV-1 Viral Load Monitoring in Adults and Children Receiving Antiretroviral Treatment in Kenya: Implications for Scale-up in Resource-Limited Settings.
    Schmitz ME; Agolory S; Junghae M; Broyles LN; Kimeu M; Ombayo J; Umuro M; Mukui I; Alwenya K; Baraza M; Ndiege K; Mwalili S; Rivadeneira E; Ngʼangʼa L; Yang C; Zeh C;
    J Acquir Immune Defic Syndr; 2017 Apr; 74(4):399-406. PubMed ID: 28002185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dried blood spots for viral load monitoring in Malawi: feasible and effective.
    Rutstein SE; Hosseinipour MC; Kamwendo D; Soko A; Mkandawire M; Biddle AK; Miller WC; Weinberger M; Wheeler SB; Sarr A; Gupta S; Chimbwandira F; Mwenda R; Kamiza S; Hoffman I; Mataya R
    PLoS One; 2015; 10(4):e0124748. PubMed ID: 25898365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Bertagnolio S; Parkin NT; Jordan M; Brooks J; García-Lerma JG
    AIDS Rev; 2010; 12(4):195-208. PubMed ID: 21179184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan children.
    Chohan BH; Tapia K; Merkel M; Kariuki AC; Khasimwa B; Olago A; Gichohi R; Obimbo EM; Wamalwa DC
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):e87-93. PubMed ID: 23542638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.